Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Leases Leasing > Getting Your Venture Lease Approved

Tags

  • financing
  • patients
  • venture capitalists
  • satisfactory payment
  • satisfactory payment

  • Links

  • What You Should Know About Fat Loss Before You Start A Self Program Of Dieting or Exercise
  • The Things You Dont Like About Other People Say More About You Than It Does About Them!
  • Affiliate Marketing - Getting Started in Affiliate Marketing and Affiliate Reveue
  • Top Articles - Getting Your Venture Lease Approved

    Each year venture capitalists fund more than 2,500 start-up companies in the U.S. Many of these companies try to conserve their equity capital by approaching venture-leasing firms to secure equipment financing. By obtaining lease financing, these savvy firm
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    s are able to use their equity capital for high-impact activities like recruiting key personnel, product development, and expanding their marketing efforts.

    What are the qualities that make some start-ups more attractive than others to venture lessors? Here
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    are ten factors that most venture lessors evaluate to decide which start-ups to finance:

    Caliber of the Management Team

    Most venture lessors consider the start-up’s management team to be the most critical success factor for the venture. Though it can be ch
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    llenging to quickly evaluate management talent, there are several qualities that venture lessors consider. They look for experienced managers with high integrity and a proven history of business performance.

    Quality of the Venture Capital Sponsors

    Another
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    mportant factor for most venture lessors is the quality of the start-up’s venture capital sponsors. Venture lessors look for experienced venture capitalists with successful investment performance over a number of years. The venture capitalists should also ha
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ve good reputations for dealing fairly with creditors serving their portfolio companies. Before entering new lease arrangements, most venture lessors verify that the start-ups’ venture capital sponsors are actively supporting them.

    Soundness of the Business
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    Plan

    Successful start-ups usually have compelling, well-articulated business plans. Lessors look for signs that the start-ups have promising market opportunities, clear and credible projections, and reliable financial statements.

    Cash Position /Monthly Bur
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Rate

    A yardstick used by many venture lessors to measure risk is the start-up’s projected cash consumption rate. The ratio of available cash to the start-up’s monthly burn rate is a useful measure. It crudely determines how long the start-up can last befor
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    a new equity round is needed. The lessor views a transaction as less risky if the start-up can make full payments during a significant portion of the lease term without raising additional equity. Most lessors look for a ratio that supports at least 9 – 12 m
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    onths of the start-up’s operation.

    Equipment Quality

    The quality and intended use of the equipment is an important factor for most venture lessors. Most lessors look for transactions involving equipment that is essential to the start-up’s operation. Additi
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    nally, the equipment should have acceptable collateral value and be readily re-marketable in the equipment aftermarket.

    Product Prospects and Revenue Track Record

    If the start-up is in the development stage and has yet to sell products, venture lessors gen
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    rally look for products capable of establishing a strong market position. If the start-up’s product is already in distribution, lessors look for strong monthly or quarterly revenue growth. A poor reception of the product in the early stages, when measured ag
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    inst the business plan, can often signal a faulty product launch or faulty product concept.

    Valuation History

    A valuation history records the share prices of stock sold to investors by the start-up. Unless there is a good explanation, most lessors look for
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    significant share price appreciation over successive offering rounds. The assumption is that the start-up is making steady and significant progress in its development, which will be reflected in rising share values.

    Balance Sheet Strength

    Venture lessors
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    sually evaluate a start-up’s working capital to ensure that the start-up can make payments when due. Along with an analysis of the start-up’s burn rate, lessors use traditional working capital measures like the current and quick ratios. Lessors also look for
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    other signs of balance sheet strength, such as: low to moderate leverage; positive tangible net worth (inclusive of subordinated debt); and minimum paid-in capital of $7 - $10 million.

    Outside Professional Involvement

    Most venture lessors view the involvem
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    nt of reputable and successful outside board members as a positive factor for start-ups. A reputable CPA firm, law firm, institutional partners and/or service providers are also viewed by lessors as positive. These professionals can bring valuable expertise
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    and contacts that can help the new venture to succeed.

    Payment Performance

    As with more traditional lessees, venture-leasing companies frown upon poor lessee payment histories. Most venture lessors expect lessees to have satisfactory payment histories, un
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ess good explanations can be offered. Like other vendors, satisfactory payment of bills by customers is where the rubber meets the road. Whether the lessee is a start-up or a Fortune 500 company, most lessors view prompt payment as sacrosanct.

    While venture
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    lessors use additional factors to make their credit decisions, these ten factors seem to be used universally. Though most of these factors are subjective, they have stood the test of time for venture lessors in making informed and reasonable credit decisions


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/104821/toparticles-Getting-Your-Venture-Lease-Approved.html">Getting Your Venture Lease Approved</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/104821/toparticles-Getting-Your-Venture-Lease-Approved.html]Getting Your Venture Lease Approved[/url]

    Related Articles:

    Secrets of Expired Domain Name Traffic

    Some Guidelines On Choosing A Credit Counseling Agency

    High Interest Investing with Low Low Low Risk

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com